Fig. 9From: Validation of a yellow fever vaccine model using data from primary vaccination in children and adults, re-vaccination and dose-response in adults and studies with immunocompromised individualsFifth scenario: dose-response. Simulation of antibody levels curves until 1000 days of vaccination, considering distinct vaccine doses (31 IU, 158 IU, 587 IU, 3,013 IU, 10,447 IU and 27,476 IU)Back to article page